The literature does not contain reports regarding teicoplanin overdose
in newborns. In a neonate with a history of recent postasphyctic acut
e renal failure which recovered within 7 days of life, antibiotic ther
apy with teicoplanin was started for sepsis due to Staphylococcus homi
nis. However, for 5 days the dosage was excessive (20 mg/kg twice dail
y instead of an initial dose of 16 mg/kg and then doses of 8 mg/kg onc
e daily). Once this error had been noted, therapy was immediately susp
ended. Clinically the newborn had improved and blood culture at the en
d of the therapy was negative. Biohumoral tests revealed constantly no
rmal levels of serum creatinine, serum cystatin C and blood nitrogen.
Urinary parameters of tubulotoxicity were also within normal values. U
rinary epidermal growth factor was increased. Teicoplanin was well tol
erated at the renal level in the newborn even in this case of excessiv
e dosage.